This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 5 from Patent US 8076284
General Information
DRACP ID DRACP01586
Peptide Name Sequence 5 from Patent US 8076284
Sequence FLGWLFKWASKVL
Sequence Length 13
UniProt ID Not available
PubChem CID Not available
Origin Synthetic construct
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antimicrobial
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification X=Xaa
Chiral L
Physicochemical Information
Formula C83H119N17O15
Absent amino acids CDEHIMNPQRTY
Common amino acids L
Mass 180919
Pl 10.81
Basic residues 2
Acidic residues 0
Hydrophobic residues 9
Net charge 2
Boman Index 1767
Hydrophobicity 93.85
Aliphatic Index 120
Half Life
Mammalian:
Yeast:
E.coli:
Extinction Coefficient cystines 11000
Absorbance 280nm 916.67
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 8076284 B2
Patent Title Analogues of antimicrobial and anticancer peptide synthesized and produced from Gaegurin 5.
Other Iinformation Granted Patent Family: 9s / 9ex; Family Jurisdictions: EP, KR, US, WO, JP, CN; Legal Status: Active; Application No: 30102807; Filed:May 14, 2007; Published: Dec 13, 2011; Earliest Priority: May 16, 2006; Granted: Dec 13, 2011
Other Published ID CN101443352A EP2016094A1 EP2016094A4 US20100105626 WO2007133033A1
This work is licensed under a Creative Commons Attribution 4.0 International License.